Phase 1, Randomized, Double-Blind, Placebo-Controlled Exploratory Study That Will Assess the Safety, Tolerability, Pharmacokinetics and Hemodynamic Response to a Single 30 Minute Intravenous Infusion of Vasomeraâ„¢ (PB1046) in Adult Subjects With Stage 1 or 2 Essential Hypertension